INCY vs ORMP
Incyte Corporation (INCY) versus Oramed Pharmaceuticals Inc (ORMP) — a side-by-side from cached financials, not a winner call.
Incyte Corporation (INCY) is a biotechnology company listed on US.
Oramed Pharmaceuticals Inc (ORMP) is a biotechnology company listed on US.
Latest reported INCY revenue for 2024-12-31 was $4.24B. Net income was $32.6M. Revenue was up 14.8% from 2023-12-31 to 2024-12-31. INCY currently screens at market cap $20.45B and trailing P/E 14.5.
Latest reported ORMP revenue for 2023-12-31 was $1.3M. Net income was $5.5M. Revenue was up 48.2% from 2022-12-31 to 2023-12-31. ORMP currently screens at market cap $87.2M.
INCY currently screens at market cap $20.45B and trailing P/E 14.5. ORMP currently screens at market cap $87.2M.
Not investment advice. Open the INCY and ORMP stock pages for the full models.
Not investment advice.